Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing
Active, not recruiting · NCT07281014 · Registry updated 2026-08-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Unmitigated Aldosterone Signaling During Standard Clinical MRA Dosing | cardiovascular disorder, heart disorder, heart failure | Active, not recruiting | Phase 4 | 2026-08-26 | NCT07281014 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Boehringer Ingelheim | 158 |
| Yale University | 458 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Yale University | New Haven | United States | 76 |